Jeena Sikho LifecareNSE:JSLL +3.81%91 ROE % is 38.65% as of Mar. 2026, which is 20% below its 10-year median of 48.11. GuruFocus rates NSE:JSLL with a GF Score™ of 91/100 and a GF Value™ of ₹771.54 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 628 Healthcare Providers & Services companies, Jeena Sikho Lifecare ranks better than 96.18% on this metric.
The historical rank and industry rank for Jeena Sikho Lifecare's ROE % or its related term are showing as below:
NSE:JSLL'
s ROE % Range Over the Past 10 Years
Min: 34.36 Med: 48.11 Max: 74.95
Current: 60.84
During the past 8 years, Jeena Sikho Lifecare's highest ROE % was 74.95%. The lowest was 34.36%. And the median was 48.11%.
NSE:JSLL's ROE % is ranked better than 96.18% of 628
companies
in the Healthcare Providers & Services industry
Industry Median: 5.72
vs NSE:JSLL: 60.84
Jeena Sikho Lifecare (NSE:JSLL) ROE % Explanation
ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.
The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:
Note:
The net income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net Income is used.
Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Jeena Sikho Lifecare's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jeena Sikho Lifecare ROE % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jeena Sikho Lifecare's ROE % distribution charts can be found below:
* The bar in red indicates where Jeena Sikho Lifecare's ROE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
ROE % is displayed in the 30-year financial page.
Jeena Sikho Lifecare (NSE:JSLL) has a ROE % of 38.65% as of Mar. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Jeena Sikho Lifecare and its competitors. This is 20% below median its historical median of 48.11. Over the past decade, Jeena Sikho Lifecare's ROE % has ranged from 34.36 to 74.95. According to the industry distribution chart, Jeena Sikho Lifecare ranks #24 out of 628 companies in the Healthcare Providers & Services industry, placing it in the top 3.8%.
Is Jeena Sikho Lifecare's ROE % too high?
Jeena Sikho Lifecare's current ROE % of 38.65% is 20% below median its 10-year median of 48.11. Over the past 10 years, this metric has ranged from a low of 34.36 to a high of 74.95. The Healthcare Providers & Services industry median ROE % is 5.72. Jeena Sikho Lifecare's value of 38.65% is 575.7% above this industry median. Based on the distribution chart, Jeena Sikho Lifecare ranks #24 out of 628 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Jeena Sikho Lifecare has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jeena Sikho Lifecare's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jeena Sikho Lifecare ranks #24 out of 628 companies for ROE %. This places Jeena Sikho Lifecare in the top 4% of its industry — outperforming the majority of peers. The industry median ROE % is 5.72. Jeena Sikho Lifecare's value of 38.65% is 575.7% above this benchmark. Historically, Jeena Sikho Lifecare's own ROE % has ranged from 34.36 to 74.95 over the past decade. While the company's 10-year median is 48.11 vs. the industry median of 5.72, Jeena Sikho Lifecare has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.72, based on 628 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jeena Sikho Lifecare's current ROE % of 38.65% is 575.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Jeena Sikho Lifecare and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jeena Sikho Lifecare's current ROE % is 38.65%, which is 20% below median its own 10-year median of 48.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jeena Sikho Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Jeena Sikho Lifecare (NSE:JSLL) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹771.54, compared to a current price of ₹602.25 — trading 21.9% below its estimated fair value. The current ROE % is 38.65%, which is 20% below median its 10-year median of 48.11 and 575.7% above the Healthcare Providers & Services industry median of 5.72. Jeena Sikho Lifecare's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Jeena Sikho Lifecare (NSE:JSLL), the current ROE % is 38.65% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jeena Sikho Lifecare (NSE:JSLL) Overvalued in 2026?
Based on GuruFocus' analysis, Jeena Sikho Lifecare stock appears to be undervalued.
The current stock price of ₹602.25 is trading 21.9% below its estimated GF Value™ of ₹771.54.
GuruFocus considers Jeena Sikho Lifecare to be Modestly Undervalued.
Key valuation signals for NSE:JSLL:
ROE %: 38.65% (20% below median its 10-year median of 48.11)
GF Value™: ₹771.54 vs. price of ₹602.25 (21.9% below fair value)
Industry Position: 575.7% above the Healthcare Providers & Services median (#24 of 628)
No single metric tells the full story. See the NSE:JSLL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jeena Sikho Lifecare Ltd provides Ayurvedic healthcare products and services. The company operates only in one business segment which is Trading of Ayurvedic Medicines and providing Ayurvedic therapies. The company engages in conducting health check-up camps, and free yoga sessions to make people aware of health problems. It offers a wide range of Ayurvedic products such as Shuddhi 32 Herbs Tea, Shuddhi Addiction Free Kit, Shuddhi BP Package, Shuddhi Diabetes Care Package, and Shuddhi Divya Sanjeevani-Anti-Viral Package.
91GF Score
Get the complete analysis for NSE:JSLL
ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:JSLL has been successfully added to your 
